$PLNeutralMed

Planet Labs Q1 Loss Widens, But Revenue Jumps 42%

Planet Labs PBC reported a wider Q1 net loss of $138.9 million ($0.40/share) versus a $12.6 million loss ($0.04/share) a year earlier, largely due to a one-time non-cash $106.5 million charge from revaluing warrant liabilities. Revenue rose 42% to $94.2 million. Adjusted loss was $8.8 million ($0.03/share). The company forecast Q2 revenue of $102–$107 million and FY2027 revenue of $425–$441 million.

9/10
8/10
Med
Neutral
after-hours / post-market reaction to Q1 print and Q2 revenue guidance
Revenue beat/strong demand narrative can support risk-on positioning even with wider GAAP loss headline.

Despite a larger reported loss, revenue growth and Q2/FY27 guidance are the key drivers for near-term positioning.

Planet Labs reported Q1 results with a widened net loss driven by a $106.5M non-cash warrant revaluation and raised revenue outlook.

Likely choppy reaction: initial loss headline pressure offset by revenue growth and reiterated FY27 outlook.

Background

Planet Labs is a satellite data company; this quarter’s loss widened largely due to non-cash warrant liability revaluation after stock price appreciation.

Why it matters

The market is likely to focus on the magnitude of the non-cash charge versus the quality of revenue growth and the company’s provided forward revenue ranges.

Market relevance

A single-stock earnings/guidance update with a clear accounting overhang but supportive revenue trajectory and forward guidance.

Market effects

Signals continued demand strength for space/defense satellite data services, though warrant-driven accounting noise may complicate earnings read-through.

No specific regional spillover mentioned.

Government/defense demand emphasis may reinforce broader defense-space capex sentiment.

Alternative perspectives

The widened GAAP loss is dominated by a non-cash warrant revaluation tied to stock price moves, so fundamentals may be less deteriorating than the headline implies.

Traders should separate cash operating performance from warrant revaluation effects and watch whether government/defense demand is translating into durable contract backlog beyond revenue guidance.

Key entities

  • Planet Labs PBC

    Reported Q1 widened net loss (non-cash warrant revaluation) alongside 42% revenue growth and issued Q2/FY27 revenue guidance.

  • Warrant liabilities revaluation

    Approximately $106.5M non-cash loss from revaluing warrant liabilities following stock price appreciation.

Related articles

$PLMedAI 9/10

Planet Labs Posts Record Quarterly Revenue, Stock Slides Anyway - Planet Labs (NYSE:PL)

Planet Labs reported Q1 adjusted loss of 3 cents per share, better than the 4-cent consensus, and revenue of $94.15 million, above the $89.85 million estimate and up 42% year over year. Remaining performance obligations rose to $816 million and backlog to $906+ million. The company raised FY2027 revenue guidance to $425–$441 million. Shares were down about 7.6% to $40.22.

$PLMedAI 9/10

Planet Labs (PL) To Report Earnings Tomorrow: Here Is What To Expect

Planet Labs (NYSE: PL) will report earnings Thursday after market close, according to the article. Last quarter, it reported revenue of $86.82 million, up 41.1% year on year, and beat analysts’ revenue and EPS estimates. For the upcoming quarter, analysts expect revenue growth of 36.2% y/y. The article cites an average analyst price target of $35.50 versus a $48.20 current share price.

$RKLBMed

RKLB, LUNR, SPCE, and Planet Labs May Crash Ahead of SpaceX IPO

Space stocks have surged this year on expectations for a SpaceX IPO that could value the company above $1.7 trillion, with Polymarket traders projecting over $2 trillion. The Procure Space ETF (UFO) is up 146% in 12 months; Rocket Lab (RKLB) is up 382% to a $83B market cap. The article warns of a “buy the rumor, sell the news” pullback and high valuations (Planet Labs forward P/S 51; RKLB 91).

$SPCEMedAI 9/10

Virgin Galactic Crashes 32% on Settlement Dilution Fears, AST SpaceMobile Rises 10%, Planet Labs Climbs 9%

Virgin Galactic (SPCE) fell about 32% after preliminary court approval for a shareholder derivative settlement revived dilution concerns tied to its capital realignment plan, which included debt restructuring and new share issuance. AST SpaceMobile (ASTS) rose about 10% after reaffirming FY2026 revenue guidance of $150M–$200M and confirming three Falcon 9 launches in mid-June. Planet Labs (PL) gained about 9% on quarterly revenue of $81.25M (+33% YoY) and higher remaining performance obligations